J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Execution of a Trade Mark License Agreement with Novartis Innovative Therapies AG, Switzerland for a portfolio of select ophthalmology brands and promotion & distribution agreement with Novartis Healthcare Private Limited, India for the same select ophthalmology brands.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Lakshay Kataria as Chief Financial Officer of the company w.e.f. November 30, 2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 10210 Shares.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Presentation'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript of Investors/Analyst call

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Audio recording of Investors/analysts call with Management

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for the quarter and half year ended on September 30, 2023

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2023, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 78440 Shares.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Grant of 21000 Options.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Amendment to the Employee Stock Option Scheme '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 27490 Shares.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 11, 2023, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Lakshay Kataria as Chief Financial Officer of the company w.e.f. November 30, 2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Split/Subdivision is 18-Sep-2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding voting results of Annual General Meeting held on August 24, 2023 along with a copy Scrutinizers report .

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 24, 2023

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Receipt of ANDA approval for Doxepin Hydrochloride Capsules USP from US FDA'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript of Investors/Analysts call

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Audio recording of Investors/analysts call with Management

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for quarter ended on June 30, 2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 09, 2023, titled "Press release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Grant of 83497 Options.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about setting-up of proposed step-down subsidiary.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 19090 Shares.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the financial year 2022-23'.